Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geumsan Black Ginseng is a South Korean health supplement company specializing in the production of premium black ginseng products. Located in Geumsan, the primary hub for ginseng cultivation in Korea, the company utilizes the traditional Gujeung-gupo process, which involves steaming and drying ginseng nine times to enhance its bioactive properties. This process significantly increases the concentration of specific ginsenosides, such as Rg3, Rh2, and Compound K, which are known for their antioxidant and immune-boosting effects. The company maintains rigorous quality standards, holding Good Agricultural Practices (GAP) and Good Manufacturing Practices (GMP) certifications. Their product line includes concentrated extracts, tonics, and powders distributed both domestically and to international markets including the United States and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Geumsan Black Ginseng.